s6y Mentari Therapeutics, Inc. EFFECT

Mentari Therapeutics, Inc. EFFECT, filed Feb 11, 2022: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 11, 2022 4:00 P.M.
Form: S-3
CIK: 0001728328
Company Name: InMed Pharmaceuticals Inc.
File Number: 333-262532